About me

Experience:

2023 -

Present

Director, MRC/NIHR Rare Disease Research UK Cardiovascular Initiative

2023 -

Present

Honorary Consultant Cardiologist (Imperial Healthcare NHS Trust)

2022 -

Present

Professor of Cardiovascular and Genomic Medicine (Imperial College London)

2022 -

Present

NIHR Imperial Biomedical Research Centre Cardiovascular theme lead

2018 -

Present

Visiting scientist (Broad Institute of MIT & Harvard, USA)

2018 -

2022

Reader (Imperial College London)

2015 -

Present

MRC LMS Group Head

2015 -

Present

Honorary Consultant Cardiologist (Royal Brompton)

2015 -

Present

Honorary Consultant Cardiologist (Royal Brompton & Harefield Hospitals)

2015 -

2018

Clinical Senior Lecturer (Imperial College London)

2014 -

2015

Postdoctoral Research Fellow (Harvard & Broad Institute, USA)

2014 -

2015

Postdoctoral Research Fellow (Harvard University, USA)

2013 -

2017

NIHR Royal Brompton Cardiovascular Biomedical Research Unit Associate theme lead

2012 -

2015

NIHR Academic Clinical Lecturer (Imperial College London)

2011 -

2012

Postdoctoral Research Fellow (MRC LMS)

2012 -

 

PhD (Imperial College London)

2008 -

2012

Wellcome Trust Clinical Research Training Fellowship

2007 -

2008

NIHR Academic Clinical Fellow (Imperial College London)

2006 -

 

MRCP

1997 -

2002

BA MB BChir MA (University of Cambridge, UK)

Research focus:

My research aims to understand the impact of genetic variation on the heart and circulation, and to use genome information to improve patient care. Working with collaborators in the UK and internationally, my team are identifying new genes and pathways underlying cardiovascular conditions that run in families, developing tools to analyse genomes & interpret genetic variation, and exploring new ways of using data from patients’ genomes to improve their treatment. Alongside my own research programme, I am Director of the national Rare Disease Research UK Cardiovascular Initiative, co-lead of the NIHR Imperial Biomedical Research Centre Cardiovascular Theme, and run the Heart Hive web research-engagement platform which connects people looking to participate in research with suitable study opportunities. My clinical interests include the management of Inherited Cardiac Conditions, the prevention of sudden cardiac arrest, and the broader application of genetics and genomics to healthcare.

Joined LMS:

2015

About me:

I am a group head at the LMS; Professor of Cardiovascular and Genomic Medicine at Imperial College London; a Consultant Cardiologist at Royal Brompton Hospital and Hammersmith Hospital; and a Visiting Scientist at the Broad Institute of MIT & Harvard. I went to University in Cambridge, trained clinically in London & Geneva, and pursued research training at Imperial & LMS, Harvard Medical School, and the Broad Institute, before starting a research group at Imperial and the LMS in 2015.

I joined the LMS because of the people working here. I have collaborators with complementary interests and expertise with whom I work very closely, alongside a diverse network of colleagues who bring very different perspectives and approaches to life & science. They are encouraging, supportive, challenging, and great fun to work with.

My awards and achievements:

Fellowship of the European Society of Cardiology (2021)

Sir Jules Thorn Award for Biomedical Research (2021)

British Cardiovascular Society Michael Davies Early Career Award (2017)

Impact of my work:

Our work has a direct impact on the diagnosis and treatment of inherited cardiovascular conditions, such as cardiomyopathy. Previously our work has focused on using genetic tests for diagnosis and prognosis. Now, with an increasingly sophisticated toolbox of technologies to repair or replace faulty genes, we are also working to develop and evaluate new genetic therapies. We are also passionate about training the scientists of the future, and about supporting patients and the public to direct the research agenda and directly participate in research.

My Research

Cardiovascular genomics precision medicine

We aim to understand the genetic basis of cardiovascular disease in order to both reveal disease mechanisms, thereby identifying new therapeutic targets, and to interpret genomic information for application in patient care.

VIEW MY RESEARCH GROUP

Selected publications

Zheng SL, […], Ware JS. Evaluation of polygenic score for hypertrophic cardiomyopathy in the general population and across clinical settings. In press at Nat. Genet. (medRxiv 10.1101/2023.03.14.23286621)

Zheng SL, Henry A, […], Ware JS* (joint senior). Lumbers RT*. Genome-wide association analysis reveals insights into the molecular etiology underlying dilated cardiomyopathy. Nat. Genet. (2024). https://doi.org/10.1038/s41588-024-01952-y

Tadros, […], Ware JS* (joint senior), Bezzina CR, Watkins H. Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy .In press at Nat. Genet. medRxiv 10.1101/2023.01.28.23285147

Curran L, […], Ware JS, O’Regan DP. Genotype-phenotype taxonomy of hypertrophic cardiomyopathy. Circ Genom Precis Med. 2023;16:e004200.

Arbelo E, […], Ware JS, Kaski JP. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J­. 2023:44;3503.

Whiffin N, […], MacArthur DG, Ware JS. (2020). Characterising the loss-of-function impact of 5′ untranslated region variants in 15,708 individualsNature Communications, 11, 2523.

Mazzarotto F, […], Ware JS* (joint senior), Walsh R. (2020). Reevaluating the Genetic Contribution of Monogenic Dilated CardiomyopathyCirculation, 141:387–398

Meyer HV, […], O’Regan DP. (2020). Genetic and functional insights into the fractal structure of the heartNature, 584; 589–594.

Karczewski KJ, Franciolo LC, Tiao G, […], Daly MJ, MacArthur DG. (2020). The mutational constraint spectrum quantified from variation in 141,456 humansNature, 581, 434–443.

Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, […], Ware JS* (joint senior), Seidman CE. (2019). Genetic Variants Associated With Cancer Therapy–Induced CardiomyopathyCirculation, 140:31–41.

Ware JS, Amor-Salamanca A, […], Barton PJ, Garcia-Pavia P. (2018). Genetic Etiology for Alcohol-Induced Cardiac ToxicityJournal of the American College of Cardiology, 71 (20), 2293-2302.

Ware JS, Cook SA. (2018). Titin cardiomyopathy: from DNA variant to patient stratificationNature Review Cardiology (invited review) 15(4), 241. 10.1038/nrcardio.2017.190.

Whiffin N, Minikel E, […], MacArthur DG, Ware JS. (2017). Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcometric genesEuropean Heart Journal, 38(42) 3119-3121.

Schafer S, de Marvao A, […], Ware JS* (joint senior), Hubner N, Cook SA. (2017). Using high-resolution variant frequencies to empower clinical genome interpretation. Genet Med 19, 1151.

Schafer S, de Marvao A, [32 authors], Ware JS (joint senior), Hubner N, Cook SA. (2017). Titin truncating variants affect heart function in disease cohorts and the general population. Nature Genetics 49, 46.

Lek M, […], Daly MJ, MacArthur DG, Exome Aggregation Consortium. (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285.

Ware JS, Li J, Mazaika E, […], Seidman CS, Seidman JG, Arany Z. (2016). Shared genetic predisposition in peripartum and dilated cardiomyopathiesNew England Journal of Medicine 374, 233.

Homsy J, Zaidi S, Shen Y, Ware JS* (joint first author), […], Seidman C, Chung W. (2015). Genetic Causes for Congenital Heart Disease with Neurodevelopmental and other DeficitsScience 350, 1262.

View all Publications View Imperial